Skip to main content
Top

Current Cardiology Reports

Issue 3/2021

Content (12 Articles)

5-FU Cardiotoxicity: Vasospasm, Myocarditis, and Sudden Death

  • Cardio-Oncology (TG Neilan, Section Editor)

Luis Alberto More, Sarah Lane, Aarti Asnani

Immunotherapy-Associated Cardiotoxicity of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T Cell Therapy: Diagnostic and Management Challenges and Strategies

  • Myocarditis
  • Cardio-Oncology (TG Neilan, Section Editor)

Ashley F. Stein-Merlob, Michael V. Rothberg, Patrick Holman, Eric H. Yang

Cardiovascular Disease Amongst Women Treated for Breast Cancer: Traditional Cytotoxic Chemotherapy, Targeted Therapy, and Radiation Therapy

Daniel H. Chen, Sara Tyebally, Michael Malloupas, Rebecca Roylance, Emma Spurrell, Fharat Raja, Arjun K. Ghosh

Comprehensive Care Models for Cardiometabolic Disease

  • Care
  • Diabetes and Cardiovascular Disease (D Bruemmer, Section Editor)

Cara Reiter-Brennan, Omar Dzaye, Dorothy Davis, Mike Blaha, Robert H. Eckel

Treatment of Hypertension in Patients with Diabetes Mellitus: a Contemporary Approach

  • Albuminuria
  • Diabetes and Cardiovascular Disease (D Bruemmer, Section Editor)

Ben Alencherry, Luke J. Laffin

Bioresorbable Scaffolds in Percutaneous Coronary Intervention: Facing Old Problems, Raising New Hopes

  • Arterial Diseases
  • Interventional Cardiology (SR Bailey and T Helmy, Section Editors)

Giulia Masiero, Giulio Rodinò, Mauro Boiago, Yuji Matsuda, Giuseppe Tarantini

Predictors of Microvascular Reperfusion After Myocardial Infarction

Daniel J. Doherty, Robert Sykes, Kenneth Mangion, Colin Berry

Reconsidering the Polypill for Management of Cardiovascular Risk Factors in Underserved Patients

  • Atorvastatin
  • Ischemic Heart Disease (D Mukherjee, Section Editor)

Tracy E. Macaulay, Erica Sheridan, Sara Ward

Reliability and Reproducibility of Absolute Myocardial Blood Flow: Does It Depend on the PET/CT Technology, the Vasodilator, and/or the Software?

K. Lance Gould, Linh Bui, Danai Kitkungvan, Monica B. Patel

The Current Evidence for Lipid Management in Patients with Lower Extremity Peripheral Artery Disease: What Is the Therapeutic Target?

  • Statins
  • Peripheral Vascular Disease (WS Jones, Section Editor)

Jennifer A. Rymer, Rajesh V. Swaminathan, Aaron W. Aday, Manesh R. Patel, J. Antonio Gutierrez

Obstructive Sleep Apnea Syndrome as a Trigger of Cardiac Arrhythmias

Julio Martí-Almor, Jesús Jiménez-López, Benjamin Casteigt, Javier Conejos, Ermengol Valles, Núria Farré, Miquel Félez Flor

Clinical Utility of Echocardiographic Strain and Strain Rate Measurements

Kawa Haji, Thomas H. Marwick

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME